David Vs Goliath – Flarin’s Macmillen On Slugging It Out With The Heavyweights

HBW Insight Exclusive: Flarin boss Andrew Macmillen on competing with the big OTC incumbents as a lean, innovation-focused company.

Box fighters trainning outdoor . Mixed media
• Source: Shutterstock

With its unique lipid technology, UK ibuprofen brand Flarin has been increasing market share up against heavy hitting brands like GlaxoSmithKline’s Voltarol and Reckitt Benckiser’s Nurofen since launching at the beginning of 2018.

Relying on lipids – a macrobiomolecule derived from pharmaceutical-grade fats of plant origin – rather than water-based liquids for delivery,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business